Darryl G. Turner

Edinburgh, SCT EH164UX, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

An Immunomodulating Peptide with Potential to Promote Anticancer Immunity Without Compromising Immune Tolerance.

An Immunomodulating Peptide with Potential to Promote Anticancer Immunity Without Compromising Immune Tolerance.

Journal: Biomedicines

Published: June 28, 2025

Optimization of Cyclophilin B-Targeted Tri-vector Inhibitors for Novel MASH Treatments.

Optimization of Cyclophilin B-Targeted Tri-vector Inhibitors for Novel MASH Treatments.

Journal: Journal of medicinal chemistry

Published: March 12, 2025

A novel immunomodulating peptide with potential to complement oligodeoxynucleotide-mediated adjuvanticity in vaccination strategies.

A novel immunomodulating peptide with potential to complement oligodeoxynucleotide-mediated adjuvanticity in vaccination strategies.

Journal: Scientific reports

Published: June 27, 2024

An immunomodulating peptide with potential to suppress tumour growth and autoimmunity.

An immunomodulating peptide with potential to suppress tumour growth and autoimmunity.

Journal: Scientific reports

Published: July 06, 2023

An immunomodulating peptide to counteract solar radiation-induced immunosuppression and DNA damage.

An immunomodulating peptide to counteract solar radiation-induced immunosuppression and DNA damage.

Journal: Scientific reports

Published: November 15, 2022

A novel lipidic peptide with potential to promote balanced effector-regulatory T cell responses.

A novel lipidic peptide with potential to promote balanced effector-regulatory T cell responses.

Journal: Scientific reports

Published: December 30, 2021

Eliminating roles for T-bet and IL-2 but revealing superior activation and proliferation as mechanisms underpinning dominance of regulatory T cells in tumors.

Eliminating roles for T-bet and IL-2 but revealing superior activation and proliferation as mechanisms underpinning dominance of regulatory T cells in tumors.

Journal: Oncotarget

Published: July 18, 2015

Methods for Ex Vivo Analysis of Immune Cell Function from the Central Nervous System.

Methods for Ex Vivo Analysis of Immune Cell Function from the Central Nervous System.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: April 13, 2015

T-bet Expression by Foxp3(+) T Regulatory Cells is Not Essential for Their Suppressive Function in CNS Autoimmune Disease or Colitis.

T-bet Expression by Foxp3(+) T Regulatory Cells is Not Essential for Their Suppressive Function in CNS Autoimmune Disease or Colitis.

Journal: Frontiers in immunology

Published: December 19, 2014

Exposure to inflammatory cytokines selectively limits GM-CSF production by induced T regulatory cells.

Exposure to inflammatory cytokines selectively limits GM-CSF production by induced T regulatory cells.

Journal: European journal of immunology

Published: March 24, 2014

Cutting edge: IL-6-dependent autoimmune disease: dendritic cells as a sufficient, but transient, source.

Cutting edge: IL-6-dependent autoimmune disease: dendritic cells as a sufficient, but transient, source.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: December 26, 2012

TLR-4 ligation of dendritic cells is sufficient to drive pathogenic T cell function in experimental autoimmune encephalomyelitis.

TLR-4 ligation of dendritic cells is sufficient to drive pathogenic T cell function in experimental autoimmune encephalomyelitis.

Journal: Journal of neuroinflammation

Published: July 05, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026